Hematopoietic
Stem cells differentiated into hematopoietic progenitors (blood-forming stem cells) are important for both cell therapy and drug development. They can be used to study various blood disorders, such as leukemia or immune system disorders.
During the development of lymphoid and myeloid lineages, hematopoietic stem cells (HSCs) differentiate into committed hematopoietic progenitors. Monitoring the expansion and differentiation of HSCs into lineage-committed hematopoietic progenitors is important for research of hematopoiesis and developing therapeutic processes with HSCs.